Trial intelligence / Profile preview

Eszopiclone and Zopiclone Residual Effects Study

NCT00699608Phase 3Completed

Sponsor
GSK
Start
Jul 2008
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of eszopiclone in Insomnia, sponsored by GSK. Started Jul 2008; status: completed.

02

Drugs

eszopiclone
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00699608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00699608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call